Cargando…
The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma
Cholangiocarcinoma (CCA) is the most common biliary malignancy, and has a poor prognosis. The median overall survival with the standard-of-care chemotherapy (Gemcitabine and cisplatin) in patients with advanced-stage CCA is less than one year. The limited efficacy of chemotherapy or targeted therapy...
Autores principales: | Huang, Wen-Kuan, Yeh, Chun-Nan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600158/ https://www.ncbi.nlm.nih.gov/pubmed/33007962 http://dx.doi.org/10.3390/biom10101396 |
Ejemplares similares
-
The Role of microRNAs in Cholangiocarcinoma
por: Shi, Tingting, et al.
Publicado: (2021) -
The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016) -
Emerging roles of microRNAs in morphine tolerance
por: Huang, Jiangju, et al.
Publicado: (2019) -
Emerging Role of microRNA Dysregulation in Diagnosis and Prognosis of Extrahepatic Cholangiocarcinoma
por: Prinz, Christian, et al.
Publicado: (2022) -
The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma
por: Wei, Ling, et al.
Publicado: (2019)